Lipoxin A4 may attenuate the progression of obesity-related glomerulopathy by inhibiting NF-κB and ERK/p38 MAPK-dependent inflammation

Obesity-related glomerulopathy: An emerging epidemic

Neeraja Kambham, Glen S. Markowitz, Anthony M. Valeri et al. · Kidney International · 2001 · 1.3K citations · Full text

Medicine, Nephrology, Nutritional Sciences +11

Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6

Hye Soon Park, Jung Yul Park, Rina Yu · Diabetes Research and Clinical Practice · 2004 · 954 citations

Medicine, Immunology, Physiology +12

The Inflammatory Cytokines TWEAK and TNFα Reduce Renal Klotho Expression through NFκB

Juan Antonio Moreno, María C. Izquierdo, María Dolores Sánchez-Niño et al. · Journal of the American Society of Nephrology · 2011 · 388 citations · Full text

Veterinary Medicine, Cell Biology, Pathobiology +17

Clinical features and long‐term outcome of obesity‐associated focal segmental glomerulosclerosis

Manuel Praga, Eduardo Hernández, Enrique Morales et al. · Nephrology Dialysis Transplantation · 2001 · 287 citations · Full text

Medicine, Nephrology, Pathology +11

Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease

Emma Börgeson, Andrew M. Johnson, Yun Sok Lee et al. · Cell Metabolism · 2015 · 225 citations · Full text

Veterinary Medicine, Biochemistry, Pharmacology +14